Guidance Eli Lilly News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The world's most valuable drugmaker hiked its full-year sales and profit guidance, despite missing lighter-than-expected first-quarter revenue.

United statesDave ricksJim cramerEli lillyJim cramer charitableDrug administrationAnexus pharmaceuticalsNovo nordiskLilly whyPfizer weightWall streetGuidance eli lillyCharitable trustHealth care industryClub earningsInvestment strategy